Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 25 July 2006. doi:10.1136/ard.2006.054866
Annals of the Rheumatic Diseases 2007;66:169-173
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2006.054866v1
66/2/169    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buch, M H
Right arrow Articles by Seibold, J R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buch, M H
Right arrow Articles by Seibold, J R

EXTENDED REPORT

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

M H Buch 1, C P Denton 2, D E Furst 3, L Guillevin 4, L J Rubin 5, A U Wells 6, M Matucci-Cerinic 7, G Riemekasten 8, P Emery 9, H Chadha-Boreham 10, P Charef 10, S Roux 10, C M Black 2, J R Seibold 1

1 University of Michigan Scleroderma Program, University of Michigan Health System, Ann Arbor, Michigan, USA
2 Centre for Rheumatology, Royal Free Campus, Royal Free and University College Medical School, London, UK
3 Division of Rheumatology, UCLA School of Medicine, University of California, Los Angeles, California, USA
4 Department of Internal Medicine, Hopital Cochin, Assistance Publique-Hopitaux de Paris, Universite Rene Descartes, Paris, France
5 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Diego, La Jolla, California, USA
6 Interstitial Lung Disease Unit, Royal Brompton Hospital, Fulham, London, UK
7 Division of Rheumatology, Department of Medicine, University of Florence, Florence, Italy
8 Department of Rheumatology and Clinical Immunology, Charite University Hospital, Berlin, Germany
9 Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds, UK
10 Actelion, Allschwil, Switzerland

Correspondence to:
Correspondence to:
Professor J R Seibold
University of Michigan Scleroderma Program, 3918 Taubman Centre, Box 0358, 1500 E Medical Center Drive, Ann Arbor, MI 48109-0358, USA; jseibold{at}umich.edu

Background: The 6-min walk test (6MWT) is increasingly used as an outcome measure in interstitial lung disease (ILD).

Aim: To evaluate the usefulness of the 6MWT in a cohort of patients with ILD secondary to systemic sclerosis (SSc) and to correlate with established physiological parameters.

Methods: 163 patients with SSc-ILD were recruited for a multicentre, randomised, double-blind clinical trial. Available data at protocol screening included repeated 6MWTs, pulmonary function testing with diffusing capacity, Doppler echocardiography and high-resolution computed tomography of the thorax. Borg Dyspnoea Index was evaluated before and after 6MWT.

Results: Mean (standard deviation (SD)) distance walked during walk test 1 was 396.6 (84.55) m compared with 399.5 (86.28) m at walk test 2. The within-subject, intertest correlation as determined by Pearson’s correlation coefficient testing was 0.95 (p<0.001). However, only weak correlations of 6MWT with percentage forced vital capacity and the Borg Dyspnoea Index were observed, and no correlation was observed with percentage diffusing capacity.

Conclusion: These data confirm the high reproducibility of the 6MWT in patients with SSc-ILD and therefore the validity of the test in this cohort. The lack of correlation of 6MWT with standard physiological parameters of ILD suggests a multifactorial basis for limited exercise capacity in patients with SSc and calls into question the utility of the 6MWT as a measure of outcome in future studies on SSc-ILD.


Abbreviations: 6MWT, six-min walk test; DLCO, single-breath diffusing capacity; FVC, forced vital capacity; HRCT, high-resolution computed tomography; IIP, idiopathic interstitial pneumonia; ILD, interstitial lung disease; OMERACT, outcome measures in rheumatological clinical trials; PAH, pulmonary arterial hypertension; SSc, systemic sclerosis




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
D. E. FURST
Measuring Outcomes in PAH: The Gap between the Measures That Are Used and Their Validity
Ann. N.Y. Acad. Sci., June 1, 2007; 1107(1): 410 - 416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism